In a report released yesterday, Mason Carrico from Stephens maintained a Buy rating on Illumina (ILMN – Research Report), with a price target ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

The carrier screening market is a crucial component of the healthcare landscape, focused on identifying carriers of genetic ...

China just fired back at the US with a massive round of tariffs, export bans, and legal action at the World Trade ...

In response to Donald Trump's increased tariffs on Chinese imports, Beijing announced additional tariffs on key agricultural ...

Real-time index price for TSX REIT Capped Index (RTRE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

The Global Rare Biomarkers Specimen Collection and Stabilization Market, valued at approximately USD 36.69 billion in 2023, is poised for significant growth, with an anticipated C ...

SAN DIEGO - Illumina, Inc. (NASDAQ: NASDAQ:ILMN), a $4.37 billion revenue genomics leader with an impressive 68.37% gross margin, today announced a comprehensive suite of new omics technologies, ...

SAN DIEGO - Illumina, Inc. (NASDAQ: NASDAQ:ILMN), a $4.37 billion revenue genomics leader with an impressive 68.37% gross margin, today announced a comprehensive suite of new omics technologies ...

BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the ...

Follow us on Facebook and join our Telegram channel for the latest updates. Prime Minister and Finance Minister Lawrence Wong mentioned Illumina, the Nasdaq-listed biotechnology firm headquartered in ...